Image courtesy of Elkus Manfredi Architects.

What: 201 Brookline Ave.
Where: Boston
Owner: Samuels & Assoc./J.P. Morgan Asset Management
Built: 2020-2022 

Boston-based Samuels & Assoc. has begun demolition work to prepare for construction of 201 Brookline Ave., a 500,000-square-foot office-lab tower. 

Venture capital firm Third Rock Ventures will move its East Coast headquarters from Newbury Street into 24,000 square feet. One of its portfolio companies, Cambridge-based Tango Therapeutics, will more than double its footprint after leasing 65,000 square feet at 201 Brookline Ave. 

Designed by Elkus Manfredi Architects, the 14-story tower will include 40,000-square-foot floor plates, lab-ready infrastructure and over 14-foot floor-to-floor heights. 

Since 2007, Third Rock Ventures has raised $2.7 billion for its investments in more than 50 life science companies, including a $55 million series A round for Tango Therapeutics in 2017. 

They Said It:  

“The Fenway has become a phenomenal backdrop for biotech and life sciences companies looking to grow and scale their workforce, in part because of the plethora of amenities, but more so the lively energy that permeates every corner of this neighborhood.” 
— Erik Grabowski, executive director of real estate Americas, J.P. Morgan Asset Management